These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 29224302

  • 21. [Clinical and pathological findings of patients with interstitial lung disease associated with antisynthetase].
    Hara H, Inoue Y, Sato T.
    Nihon Kokyuki Gakkai Zasshi; 2005 Nov; 43(11):652-63. PubMed ID: 16366363
    [Abstract] [Full Text] [Related]

  • 22. [Antisynthetase myopathy].
    Suzuki S.
    Rinsho Shinkeigaku; 2020 Mar 31; 60(3):175-180. PubMed ID: 32101845
    [Abstract] [Full Text] [Related]

  • 23. Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature.
    Labirua-Iturburu A, Selva-O'Callaghan A, Vincze M, Dankó K, Vencovsky J, Fisher B, Charles P, Dastmalchi M, Lundberg IE.
    Medicine (Baltimore); 2012 Jul 31; 91(4):206-211. PubMed ID: 22732951
    [Abstract] [Full Text] [Related]

  • 24. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies.
    Koreeda Y, Higashimoto I, Yamamoto M, Takahashi M, Kaji K, Fujimoto M, Kuwana M, Fukuda Y.
    Intern Med; 2010 Jul 31; 49(5):361-9. PubMed ID: 20190466
    [Abstract] [Full Text] [Related]

  • 25. A case with overlapping features of IgG4-related autoimmune pancreatitis, Sjögren's syndrome and anti-aminoacyl-tRNA synthetase syndrome.
    Yoshikawa M, Muro Y, Ogawa-Momohara M, Ito S, Takeichi T, Akiyama M.
    Mod Rheumatol Case Rep; 2021 Jan 31; 5(1):82-86. PubMed ID: 32867620
    [Abstract] [Full Text] [Related]

  • 26. Pulmonary Pathologic Manifestations of Anti-Alanyl-tRNA Synthetase (Anti-PL-12)-Related Inflammatory Myopathy.
    Schneider F, Yousem SA, Oddis CV, Aggarwal R.
    Arch Pathol Lab Med; 2018 Feb 31; 142(2):191-197. PubMed ID: 28967806
    [Abstract] [Full Text] [Related]

  • 27. A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease.
    Patel P, Marinock JM, Ajmeri A, Brent LH.
    Int J Mol Sci; 2024 Apr 18; 25(8):. PubMed ID: 38674039
    [Abstract] [Full Text] [Related]

  • 28. A Rare Case of Necrotizing Myopathy and Fibrinous and Organizing Pneumonia with Anti-EJ Antisynthetase Syndrome and SSA Antibodies.
    Kashif M, Arya D, Niazi M, Khaja M.
    Am J Case Rep; 2017 Apr 25; 18():448-453. PubMed ID: 28439062
    [Abstract] [Full Text] [Related]

  • 29. Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias.
    Watanabe K, Handa T, Tanizawa K, Hosono Y, Taguchi Y, Noma S, Kobashi Y, Kubo T, Aihara K, Chin K, Nagai S, Mimori T, Mishima M.
    Respir Med; 2011 Aug 25; 105(8):1238-47. PubMed ID: 21514811
    [Abstract] [Full Text] [Related]

  • 30. [A case of cellular NSIP with anti-OJ (anti-isoleucyl tRNA synthetase) antibodies].
    Shimizu K, Tai H, Kuwano K.
    Nihon Kokyuki Gakkai Zasshi; 2010 Jan 25; 48(1):45-8. PubMed ID: 20163021
    [Abstract] [Full Text] [Related]

  • 31. Pulmonary histopathology of interstitial lung disease associated with antisynthetase antibodies.
    Flashner BM, VanderLaan PA, Nurhussien L, Rice MB, Hallowell RW.
    Respir Med; 2022 Jan 25; 191():106697. PubMed ID: 34864634
    [Abstract] [Full Text] [Related]

  • 32. Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)-related inflammatory myopathy.
    Schneider F, Yousem SA, Bi D, Gibson KF, Oddis CV, Aggarwal R.
    J Clin Pathol; 2014 Aug 25; 67(8):678-83. PubMed ID: 24891607
    [Abstract] [Full Text] [Related]

  • 33. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience.
    Zhang D, Wang H, Zhou X, Yang J, Liu Y, Wang W, Jiang P, Fan B.
    Immun Inflamm Dis; 2023 Nov 25; 11(11):e1085. PubMed ID: 38018600
    [Abstract] [Full Text] [Related]

  • 34. Interstitial lung disease in a patient with antisynthetase syndrome and no myositis.
    Plastiras SC, Soliotis FC, Vlachoyiannopoulos P, Tzelepis GE.
    Clin Rheumatol; 2007 Jan 25; 26(1):108-11. PubMed ID: 16328094
    [Abstract] [Full Text] [Related]

  • 35. Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition?
    Lega JC, Cottin V, Fabien N, Thivolet-Béjui F, Cordier JF.
    J Rheumatol; 2010 May 25; 37(5):1000-9. PubMed ID: 20231208
    [Abstract] [Full Text] [Related]

  • 36. Mechanic's hands in a woman with undifferentiated connective tissue disease and interstitial lung disease--anti-PL7 positive antisynthetase syndrome: a case report.
    De Langhe E, Lenaerts J, Bossuyt X, Westhovens R, Wuyts WA.
    J Med Case Rep; 2015 Apr 15; 9():82. PubMed ID: 25888844
    [Abstract] [Full Text] [Related]

  • 37. Clinical manifestations and treatment of antisynthetase syndrome.
    Marco JL, Collins BF.
    Best Pract Res Clin Rheumatol; 2020 Aug 15; 34(4):101503. PubMed ID: 32284267
    [Abstract] [Full Text] [Related]

  • 38. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.
    Mahler M, Miller FW, Fritzler MJ.
    Autoimmun Rev; 2014 Aug 15; 13(4-5):367-71. PubMed ID: 24424190
    [Abstract] [Full Text] [Related]

  • 39. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
    Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV.
    Arthritis Rheum; 2005 Aug 15; 52(8):2439-46. PubMed ID: 16052580
    [Abstract] [Full Text] [Related]

  • 40. Jo1-antisynthetase syndrome and severe interstitial lung disease with organising pneumonia on histopathology with favourable outcome on early combined treatment with corticosteroids, mycophenolate mofetil and rituximab.
    Rüegg CA, Maurer B, Laube I, Scholtze D.
    BMJ Case Rep; 2019 Sep 12; 12(9):. PubMed ID: 31519721
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.